Skip to main content
Veterinary Medicines

Rimadyl 50 mg/ml - Injektionslösung für Hunde und Katzen

Authorised
  • Carprofen

Product identification

Medicine name:
Rimadyl 50 mg/ml - Injektionslösung für Hunde und Katzen
Active substance:
  • Carprofen
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Österreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Austrian Agency For Health And Food Safety Limited
Authorisation number:
  • 8-00434
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/08/2020

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/06/2013

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/06/2013
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."